Pregnancy after treatment with three recombinant gonadotropins [5]

Lancet

Volumn 349, Issue 9044, 1997, Pages 29-30

  Agrawal, Rina ^b   West, Chris ^b   Conway, G S ^b   Page, Mercia L ^b   Jacobs, H S ^a  

^a MIDDLESEX HOSPITAL   (United Kingdom)

^b Serono Laboratories (UK) Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; GONADORELIN; GONADOTROPIN; GROWTH HORMONE; LUTEINIZING HORMONE; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE; UNCLASSIFIED DRUG;

ADULT; ASCITES; CASE REPORT; CORPUS LUTEUM FUNCTION; CRANIOPHARYNGIOMA; DELAYED PUBERTY; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HORMONAL THERAPY; HORMONE URINE LEVEL; HUMAN; HYPOPITUITARISM; LETTER; OVARY CYST; OVARY FUNCTION; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PLEURA EFFUSION; PREGNANCY; PRIORITY JOURNAL; SHORT STATURE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031015558     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)62162-9     Document Type: Article

References (5)

1. Germond M, Dessole S, Senn A, Loumaye E, Howles C, Beltrami V. Successful in-vitro fertilisation and embryo transfer after treatment with recombinant human FSH. Lancet 1992; 339: 1170.
2. Hull M, Corrigan E, Piazzi A, Loumaye E. Recombinant human luteinising hormone: an effective new gonadotropin preparation. Lancet 1994; 344: 334-35.
3. Imthurn B, Piazzi A, Loumaye E. Recombinant human luteinising hormone to mimic mid-cycle LH surge. Lancet 1996; 348: 332-33.
4. McClure N, Healy DL, Rogers PAW, et al. Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet 1994; 344: 235-36.
5. MacDougal MJ, Tan SL, Balen AH, Jacobs HS. A controlled study comparing patients with and without polycystic ovaries undergoing in vitro fertilisation. Hum Reprod 1993; 8: 233-37.